Alemany, Silvia http://orcid.org/0000-0002-7925-6767
Avella-García, Claudia
Liew, Zeyan
García-Esteban, Raquel
Inoue, Kosuke
Cadman, Tim
López-Vicente, Mònica
González, Llúcia
Riaño Galán, Isolina
Andiarena, Ainara
Casas, Maribel
Margetaki, Katerina
Strandberg-Larsen, Katrine
Lawlor, Deborah A.
El Marroun, Hanan
Tiemeier, Henning
Iñiguez, Carmen
Tardón, Adonina
Santa-Marina, Loreto
Júlvez, Jordi
Porta, Daniela
Chatzi, Leda
Sunyer, Jordi
Funding for this research was provided by:
UK Medical Research Council and Wellcome (217065/Z/19/Z)
CERN (FP7/2007-2013/ERC grant agreement no 669545)
UK National Institute of Health Senior Investigator (NF-0616-10102)
European Union’s Horizon 2020 (733206)
University of Bristol and UK Medical Research Council (MC_UU_00011/6)
Danish National Research Foundation
Danish Regional Committees
Pharmacy Foundation
Egmont Foundation
March of Dimes Birth Defects Foundation
Health Foundation
Novo Nordisk Foundation
Lundbeck Foundation (195/04, R100-A9193)
Danish Medical Research Council (SSVF 0646, 271-08-0839/06-066023, O602-01042B, 0602-02738B)
Innovationsfonden (0603-00294B (09-067124))
Nordea Foundation (02-2013-2014)
Aarhus Ideas (AU R9-A959-13-S804)
University of Copenhagen Strategic Grant (IFSV 2012)
Danish Council for Independent Research (DFF – 4183-00594 and DFF - 4183-00152)
Italian Ministry of Health
Italian Medicines Agency
Erasmus Medical Center
Erasmus University Rotterdam
Netherlands Organization for Health Research and Development
Netherlands Organization for Scientific Research
Ministry of Health, Welfare, and Sport
Ministry of Youth and Families
NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (27853)
Vici project (016.VICI.170.200)
European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant (707404)
Instituto de Salud Carlos III (G03/176; CB06/02/0041; CP18/00018; G03/176, CB06/02/0041; FIS-FEDER: PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/1213, PI07/0314, PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, and PI17/00663)
Generalitat de Catalunya-CIRIT (1999SGR 00241)
Fundació la Marató de TV3 (090430)
Spanish Ministry of Science and Innovation (CEX2018-000806-S)
CERCA Program
Juan de la Cierva – Incorporación Postdoctoral Contract awarded by Ministry of Economy, Industry and Competitiveness (IJCI-2017-34068)
Miguel Servet-II contract (CPII19/00015)
Instituto de Salud Carlos III (Miguel Servet-FEDER CP11/00178, CP15/00025, and CPII16/00051;PI041436; PI081151; PI1100610; FISS PI 04/2018, FIISPI09/02311, FISSPI13/02429, FISS PI18/00909; FIS-PI06/0867, FIS-PI09/00090, FIS-PI18/01142 and FIS-PI13/02187; incl. FEDER funds, CP14/00108 & PI16/00261)
Cátedra Telefónica, Universidad de Oviedo
CIBERESP
Obra Social Cajastur/Fundación Liberbank
Department of Health of the Basque Government (2005111093, 2009111069, 2013111089 and 2015111065)
Provincial Government of Gipuzkoa (DFG06/002, DFG08/001 and DFG15/221)
European Union (FP7-ENV-2011 cod 282957 and HEALTH.2010.2.4.5-1; EU FP6-2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 ENV.2007.1.2.2.2. Project No 211250 Escape, EU FP7- 2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH- 2009- single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No 226285 ENRIECO, EUFP7- HEALTH-2012 Proposal No 308333 HELIX, FP7 European Union project, No. 264357 MeDALL)
Generalitat Valenciana: FISABIO (UGP 15-230, UGP-15-244, and UGP-15-249)
Alicia Koplowitz Foundation 2017
the Greek Ministry of Health
National Institute of Environmental Health Sciences (R01ES029944, R01ES030364, R21ES28903, R21ES029681, P30ES007048)
Article History
Received: 19 October 2020
Accepted: 20 April 2021
First Online: 28 May 2021
Declarations
:
: DA Lawlor declares that she has received support for research unrelated to this project from numerous national and international charity and government funders and from Medtronic Ltd and Roche Diagnostics. The rest of authors declare no conflict of interest.